It is chronic (longer than 8 weeks), 2) Inflammatory-based– that is to say, that the immune system is attacking the peripheral nerves of the body in the arms and legs, 3) Demyelinating—that ...

KLP Kapitalforvaltning AS purchased a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund purchased 10,800 shares of ...

Immunovant, Inc.’s IMVT share price has dipped by 11.06%, which has investors questioning if this is right time to buy.

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...

HighTower Advisors LLC raised its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD – Free Report) by 13.0% during the fourth quarter, according to its most recent disclosure with the ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Average rating / 5. Vote count: No votes so far! Be the first to rate this content.